Update on World Health Organization HIV Drug Resistance Prevention and Assessment Strategy: 2004-2011

被引：46

作者：

Jordan, M. R. ^{[1
,2
]}

Bennett, D. E. ^{[3
]}

Wainberg, M. A.

Havlir, D. ^{[4
]}

Hammer, S. ^{[5
]}

Yang, C. ^{[3
]}

Morris, L. ^{[6
]}

Peeters, M. ^{[7
,8
]}

Wensing, A. M. ^{[9
]}

Parkin, N. ^{[10
]}

Nachega, J. B. ^{[11
,12
]}

Phillips, A. ^{[13
]}

De Luca, A. ^{[14
,15
]}

Geng, E. ^{[4
]}

Calmy, A. ^{[16
,20
]}

Raizes, E. ^{[3
]}

Sandstrom, P. ^{[17
]}

Archibald, C. P. ^{[17
]}

Perriens, J.

McClure, C. M.

Hong, S. Y. ^{[2
]}

McMahon, J. H. ^{[2
,18
]}

Dedes, N. ^{[19
]}

Sutherland, D. ^{[17
]}

Bertagnolio, S.

机构：

[1] World Hlth Org, Dept HIV, CH-1211 Geneva 27, Switzerland

[2] Tufts Univ, Sch Med, Boston, MA 02111 USA

[3] US Ctr Dis Control & Prevent, Atlanta, GA USA

[4] Univ Calif San Francisco, San Francisco, CA 94143 USA

[5] Columbia Univ, Med Ctr, New York, NY USA

[6] Natl Inst Communicable Dis, AIDS Virus Res Unit, Johannesburg, South Africa

[7] Inst Rech Dev, UMI 233 TransVIHMI, Montpellier, France

[8] Univ Montpellier I, F-34006 Montpellier, France

[9] Univ Med Ctr Utrecht, Utrecht, Netherlands

[10] Data First Consulting, Belmont, CA USA

[11] Univ Stellenbosch, Cape Town, South Africa

[12] Johns Hopkins Bloomberg, Sch Publ Hlth, Baltimore, MD USA

[13] UCL, London WC1E 6BT, England

[14] Univ Cattolica Sacro Cuore, Inst Clin Infect Dis, Rome, Italy

[15] Siena Univ Hosp, Div Infect Dis, Siena, Italy

[16] Univ Hosp Geneva, Geneva, Switzerland

[17] Publ Hlth Agcy Canada, Ottawa, ON, Canada

[18] Alfred Hosp, Melbourne, Vic, Australia

[19] Int Treatment Preparedness Coalit, Bangkok, Thailand

[20] Med Sans Frontiere Access Campaign, Geneva, Switzerland

来源：

CLINICAL INFECTIOUS DISEASES | 2012年 / 54卷

基金：

比尔及梅琳达.盖茨基金会; 美国国家卫生研究院;

关键词：

EARLY-WARNING INDICATORS; ANTIRETROVIRAL THERAPY; VIROLOGICAL FAILURE; GENERIC PROTOCOL; PREGNANT-WOMEN; SURVEILLANCE; INDIVIDUALS; ADHERENCE; CLINICS; PREDICTORS;

D O I：

10.1093/cid/cis206

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The HIV drug resistance (HIVDR) prevention and assessment strategy, developed by the World Health Organization (WHO) in partnership with HIVResNet, includes monitoring of HIVDR early warning indicators, surveys to assess acquired and transmitted HIVDR, and development of an accredited HIVDR genotyping laboratory network to support survey implementation in resource-limited settings. As of June 2011, 52 countries had implemented at least 1 element of the strategy, and 27 laboratories had been accredited. As access to antiretrovirals expands under the WHO/Joint United Nations Programme on HIV/AIDS Treatment 2.0 initiative, it is essential to strengthen HIVDR surveillance efforts in the face of increasing concern about HIVDR emergence and transmission.

引用

页码：S245 / S249

页数：5

共 50 条

[1] The World Health Organization's global strategy for prevention and assessment of HIV drug resistance
Bennett, Diane E.
Bertagnolio, Silvia
Sutherland, Donald
Gilks, Charles F.
ANTIVIRAL THERAPY, 2008, 13 : 1 - 13
[2] An assessment of the relationship between the World Health Organization HIV drug resistance early warning indicators and HIV drug resistance acquisition
St-Jean, M.
Harrigan, P. R.
Sereda, P.
Montaner, J. S. G.
Lima, V. D.
HIV MEDICINE, 2017, 18 (05) : 342 - 353
[3] World Health Organization/HIVResNet drug resistance laboratory strategy
Bertognolio, Silvio
Derdelinckx, Inge
Parker, Monica
Fitzgibbon, Joseph
Fleury, Herve
Peeters, Martin
Schuurman, Rob
Pillay, Deenan
Morris, Lynn
Tanuri, Amilcar
Gershy-Damet, Guy-Michel
Nkengasong, John
Gilks, Charles F.
Sutherland, Donald
Sandstrom, Paul
ANTIVIRAL THERAPY, 2008, 13 : 49 - 57
[4] Progress of implementation of the World Health Organization strategy for HIV drug resistance control in Latin America and the Caribbean
Ravasi, Giovanni
Jack, Noreen
Gonzalez, Monica Alonso
Sued, Omar
Dolores Perez-Rosales, Maria
Gomez, Bertha
Vila, Marcelo
del Riego, Amalia
Ghidinelli, Massimo
REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH, 2011, 30 (06): : 657 - 662
[5] Feasibility of the World Health Organization's HIV drug resistance assessment strategy for resource-limited countries scaling up ART
Bennett, D. E.
Bertagnolio, S.
Parkin, N.
Jordan, M.
ANTIVIRAL THERAPY, 2009, 14 (04) : A161 - A161
[6] Assessment of the World Health Organization early warning indicators of HIV drug resistance in Namibia for public health action, 2015
Mutenda, N.
Nakanyala, T.
Hamunime, N.
Mekonen, T.
Tjituka, F.
Natanael, S.
Mazibuko, G.
Mwinga, S.
Mabirizi, D.
Sagwa, E.
Walkowiak, H.
Kiesling, A.
Aptekar, S.
Jordan, M.
Hong, S.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
[7] World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites
Jordan, Michael R.
Bennett, Diane E.
Bertagnolio, Silvia
Gilks, Charles F.
Sutherland, Donald
ANTIVIRAL THERAPY, 2008, 13 : 15 - 23
[8] The World Health Organization's HIV drug resistance early warning indicators: results from 50 countries 2004-2009
Bennett, D. E.
Jordan, M. R.
Bertagnolio, S.
Hong, S. Y.
Ravasi, G.
McMahon, J. H.
Kelley, K. F.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15 : 121 - 121
[9] HIV Drug Resistance Early Warning Indicators in Namibia with Updated World Health Organization Guidance
Jonas, Anna
Sumbi, Victor
Mwinga, Samson
DeKlerk, Michael
Tjituka, Francina
Penney, Scott
Jordan, Michael R.
Desta, Tiruneh
Tang, Alice M.
Hong, Steven Y.
PLOS ONE, 2014, 9 (07):
[10] European Recommendations for the Clinical Use of HIV Drug Resistance Testing: 2011 Update
Vandamme, Anne-Mieke
Camacho, Ricardo J.
Ceccherini-Silberstein, Francesca
de Luca, Andrea
Palmisano, Lucia
Paraskevis, Dimitrios
Paredes, Roger
Poljak, Mario
Schmit, Jean-Claude
Soriano, Vincent
Walter, Hauke
Sonnerborg, Anders
AIDS REVIEWS, 2011, 13 (02) : 77 - 108

← 1 2 3 4 5 →